bf/NASDAQ:ELDN_icon.jpeg

NASDAQ:ELDN

Eledon Pharmaceuticals, Inc.

  • Stock

USD

Last Close

4.10

06/11 22:30

Market Cap

93.57M

Beta: 2.12

Volume Today

113.39K

Avg: 121.43K

PE Ratio

−0.59

PFCF: −1.06

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-23.30M
-
-45.09M
93.54%
-37.96M
15.81%
-13.12M
65.45%
-14.06M
7.24%
-16.01M
13.84%
-22.81M
42.47%
-34.51M
51.27%
-87.97M
154.93%
-40.33M
54.16%
depreciation and amortization
21K
-
109K
419.05%
171K
56.88%
22K
87.13%
11K
50%
182K
1,554.55%
183K
0.55%
195K
6.56%
373K
91.28%
374K
0.27%
deferred income tax
72K
-
352K
388.89%
-404K
-
-2.35M
482.67%
stock based compensation
2.11M
-
2.90M
37.62%
3.00M
3.48%
579K
80.71%
1.54M
166.49%
1.31M
15.23%
3.17M
142.43%
7.90M
149.26%
8.15M
3.15%
change in working capital
204K
-
1.00M
392.16%
-2.08M
307.57%
-2.48M
18.76%
618K
124.97%
-1.20M
294.66%
-180K
85.04%
-152K
15.56%
2.37M
1,657.89%
-4.92M
307.64%
accounts receivables
inventory
accounts payables
760K
-
443K
41.71%
-778K
275.62%
-1.96M
151.67%
1.09M
155.87%
-1.39M
227.24%
-39K
97.20%
2.14M
5,594.87%
2.08M
2.89%
-2.60M
224.94%
other working capital
-556K
-
561K
200.90%
-1.31M
332.80%
-517K
60.41%
-476K
7.93%
189K
139.71%
-141K
174.60%
-2.29M
1,527.66%
287K
112.51%
-2.32M
907.32%
other non cash items
-158K
-
-235K
48.73%
-2K
99.15%
49K
2,550%
1.87M
-
4.83M
158.65%
48.65M
-
5.34M
89.02%
net cash provided by operating activities
-21.12M
-
-41.24M
95.24%
-36.52M
11.44%
-14.94M
59.09%
-11.89M
20.40%
-13.86M
16.51%
-15.21M
9.78%
-28.91M
90.07%
-28.42M
1.69%
-39.53M
39.06%
investments in property plant and equipment
-25K
-
-565K
2,160%
-17K
96.99%
acquisitions net
-2K
-
23.25M
1,162,600%
11.04M
-
purchases of investments
-39.88M
-
-500K
98.75%
-78.29M
-
sales maturities of investments
36.20M
-
33M
-
other investing activites
-150K
-
-70K
53.33%
2K
102.86%
8K
300%
net cash used for investing activites
-175K
-
-40.51M
23,048.57%
35.68M
188.08%
23.26M
34.82%
11.04M
-
-45.29M
-
debt repayment
-25
-
common stock issued
97.93M
-
4.75M
-
7.49M
57.71%
9.68M
29.17%
9M
6.99%
-449K
104.99%
33.02M
-
common stock repurchased
-25
-
dividends paid
-25K
-
other financing activites
-3.13M
-
513K
116.39%
37K
92.79%
3.12M
8,329.73%
71K
97.72%
9.68K
86.37%
100.61M
1,039,648.35%
net cash used provided by financing activities
94.80M
-
513K
99.46%
37K
92.79%
7.87M
21,167.57%
7.56M
3.90%
9.68M
27.96%
109.58M
1,032.50%
-449K
100.41%
33.02M
-
effect of forex changes on cash
net change in cash
73.50M
-
-81.23M
210.52%
-800K
99.02%
16.19M
2,123.25%
-4.33M
126.76%
-4.18M
3.46%
105.40M
2,621.02%
-29.36M
127.86%
-28.42M
3.19%
-51.80M
82.23%
cash at beginning of period
31.75M
-
105.26M
231.48%
24.02M
77.18%
1.12M
95.35%
17.30M
1,449.06%
12.97M
25.03%
8.79M
32.23%
114.19M
1,199.00%
84.83M
25.71%
56.41M
33.51%
cash at end of period
105.26M
-
24.02M
77.18%
23.22M
3.33%
17.30M
25.49%
12.97M
25.03%
8.79M
32.23%
114.19M
1,199.00%
84.83M
25.71%
56.41M
33.51%
4.61M
91.82%
operating cash flow
-21.12M
-
-41.24M
95.24%
-36.52M
11.44%
-14.94M
59.09%
-11.89M
20.40%
-13.86M
16.51%
-15.21M
9.78%
-28.91M
90.07%
-28.42M
1.69%
-39.53M
39.06%
capital expenditure
-25K
-
-565K
2,160%
-17K
96.99%
free cash flow
-21.15M
-
-41.80M
97.68%
-36.54M
12.59%
-14.94M
59.11%
-11.89M
20.40%
-13.86M
16.51%
-15.21M
9.78%
-28.91M
90.07%
-28.42M
1.69%
-39.53M
39.06%

All numbers in USD (except ratios and percentages)